Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Operating Expenses (2018 - 2025)

Exagen's Operating Expenses history spans 8 years, with the latest figure at $14.2 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 19.57% year-over-year to $14.2 million; the TTM value through Dec 2025 reached $52.9 million, up 13.09%, while the annual FY2025 figure was $52.9 million, 13.09% up from the prior year.
  • Operating Expenses reached $14.2 million in Q4 2025 per XGN's latest filing, up from $13.2 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $27.3 million in Q4 2022 to a low of -$4.2 million in Q4 2023.
  • Average Operating Expenses over 5 years is $15.8 million, with a median of $17.3 million recorded in 2021.
  • Peak YoY movement for Operating Expenses: tumbled 115.3% in 2023, then soared 383.73% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $18.9 million in 2021, then soared by 44.26% to $27.3 million in 2022, then tumbled by 115.3% to -$4.2 million in 2023, then skyrocketed by 383.73% to $11.9 million in 2024, then increased by 19.57% to $14.2 million in 2025.
  • Per Business Quant, the three most recent readings for XGN's Operating Expenses are $14.2 million (Q4 2025), $13.2 million (Q3 2025), and $13.0 million (Q2 2025).